Beacon Pointe Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Buy
8,524
+3,992
+88% +$860K 0.01% 767
2025
Q4
$931K Sell
4,532
-831
-15% -$156K 0.01% 859
2025
Q3
$842K Sell
5,363
-1,787
-25% -$276K 0.01% 824
2025
Q2
$1.2M Sell
7,150
-234
-3% -$34.7K 0.01% 614
2025
Q1
$1.02M Buy
7,384
+37
+0.5% +$4.72K 0.01% 632
2024
Q4
$869K Sell
7,347
-141
-2% -$16.5K 0.01% 674
2024
Q3
$828K Sell
7,488
-136
-2% -$14.2K 0.01% 687
2024
Q2
$750K Sell
7,624
-161
-2% -$16.4K 0.01% 727
2024
Q1
$871K Sell
7,785
-1,299
-14% -$140K 0.01% 735
2023
Q4
$916K Sell
9,084
-208
-2% -$20.6K 0.01% 688
2023
Q3
$807K Buy
9,292
+5,067
+120% +$458K 0.01% 700
2023
Q2
$400K Sell
4,225
-4,885
-54% -$413K 0.01% 787
2023
Q1
$688K Buy
9,110
+4,767
+110% +$360K 0.01% 656
2022
Q4
$334K Buy
+4,343
New +$330K 0.01% 824

Other funds holding CAH

Beacon Pointe Advisors's CAH Position: Q1 2026 in Review

Beacon Pointe Advisors increased its Cardinal Health (CAH) stake by 88% in Q1 2026, buying an estimated $860K and bringing the position to 8,524 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #767.

Beacon Pointe Advisors first reported a position in CAH in Q4 2022 and has held it in 14 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Beacon Pointe Advisors held 8,524 shares of Cardinal Health worth $1.8M as of Q1 2026.
  • Beacon Pointe Advisors bought 3,992 Cardinal Health shares in Q1 2026, an estimated $860K.
  • Cardinal Health made up 0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #767 holding.
  • Beacon Pointe Advisors first reported a position in Cardinal Health in Q4 2022 and has held it in 14 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.